Table 4.
Model 1 | Model 2 | |||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Outcome: All-cause deaths | ||||
TyG index | 1.182 (1.106, 1.263) | <0.001 | 1.068 (0.984, 1.160) | 0.117 |
TyG-BMI index | 1.002 (1.001, 1.003) | <0.001 | 1.002 (1.001, 1.003) | <0.001 |
TyG-WC index | 1.001 (1.001,1.002) | <0.001 | 1.001 (1.000,1.002) | <0.001 |
Outcome: Cardiovascular specific deaths | ||||
TyG index | 1.055 (0.940, 1.220) | 0.310 | 1.059 (0.897, 1.250) | 0.500 |
TyG-BMI index | 1.003 (1.001, 1.004) | 0.002 | 1.002 (1.001,1.004) | 0.005 |
TyG-WC index | 1.001 (1.000, 1.002) | 0.002 | 1.001 (1.000, 1.002) | 0.005 |
Outcome: Diabetes-specific deaths | ||||
TyG index | 1.840 (1.476, 2.290) | <0.001 | 1.077 (0.810, 1.432) | 0.610 |
TyG-BMI index | 1.009 (1.006, 1.010) | <0.001 | 1.004 (1.001, 1.010) | 0.013 |
TyG-WC index | 1.004 (1.003, 1.008) | <0.001 | 1.002 (1.001, 1.003) | 0.021 |
Survey weight-adjusted multivariable Cox proportional hazard models were performed for all-causes mortality. Competing risk analyses of cause-specific mortality were performed. Model 1 was adjusted for baseline age, sex, and race/ethnicity. Model 2 was further adjusted for income, marital status, education, smoking, sedentary lifestyle, diabetes, hypertension, plasma HDL-C, and FIB-4 in addition to model 1
BMI, Body mass index; CI, confidence intervals; FIB-4, Fibrosis-4 index; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; MASLD, metabolic dysfunction-associated steatotic liver disease; TyG, triglyceride-glucose; WC, waist circumference